Aastrom Biosciences, Inc.

Company Listings from SPi: Aastrom Biosciences, Inc.

You are here: Home >> SPi Company Listings >> Aastrom Biosciences, Inc.

 

Aastrom Biosciences, Inc.

Website:
http://

Search for other references to "aastrom" on SPi News

Latest Aastrom Biosciences, Inc. News

Aastrom Biosciences Reports Third-Quarter 2014 Financial Results ANN ARBOR, Mich., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment o...... 13:16 GMT Thursday 13th November 2014

Aastrom Biosciences Announces Plans to Change Name to Vericel Corporation and Move Headquarters to Cambridge, Massachusetts ANN ARBOR, Mich., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment of...... 22:30 GMT Thursday 9th October 2014

Aastrom Biosciences to Present Three-Year Data From the SUMMIT Extension Study of MACI(TM) at the 2015 American Academy of Orthopedic Surgeons Annual Meeting ANN ARBOR, Mich., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatmen...... 13:30 GMT Tuesday 16th September 2014

Aastrom Biosciences Announces Pricing of Public Offering of Common Stock ANN ARBOR, Mich., Sept. 11, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatmen...... 13:30 GMT Thursday 11th September 2014

Treatment With Aastrom's Ixmyelocel-T Shown to Reduce Incidence of Major Adverse Cardiovascular Events in Patients With Ischemic Dilated Cardiomyopathy ANN ARBOR, Mich., Aug. 22, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment...... 14:00 GMT Friday 22nd August 2014

Aastrom Biosciences Reports Second Quarter 2014 Financial Results ANN ARBOR, Mich., Aug. 14, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific, expanded cellular therapies for the treatmen...... 12:30 GMT Thursday 14th August 2014

Aastrom Biosciences to Host Second Quarter 2014 Earnings Call on August 14, 2014 ANN ARBOR, Mich., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment...... 14:30 GMT Monday 11th August 2014

Aastrom Announces Appointment of Zac Taylor as National Sales Director ANN ARBOR, Mich., July 14, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment...... 13:30 GMT Monday 14th July 2014

Aastrom Biosciences Added to Russell Microcap Index Aastrom Biosciences Added to Russell Microcap Index ANN ARBOR, Mich., June 30, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment...... 13:30 GMT Monday 30th June 2014

Aastrom Announces Initiation of Commercial Sales of Bone Marrow by Marrow Donation, LLC Aastrom Announces Initiation of Commercial Sales of Bone Marrow by Marrow Donation, LLC ANN ARBOR, Mich., June 24, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment...... 13:45 GMT Tuesday 24th June 2014

Buy Aastrom Biosciences, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us